{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:48Z","timestamp":1773282888288,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.tube.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T05:20:16Z","timestamp":1526707216000},"page":"41-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0855-4521","authenticated-orcid":false,"given":"Nathally Claudiane de Souza","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regiane Bertin de Lima","family":"Scodro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryadne Larissa","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Pietrowski","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Sayuri","family":"Nakamura de Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia Dias","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katiany Rizzieri","family":"Caleffi-Ferracioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Aline Zanetti","family":"Campanerut-S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosilene Fressatti","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2018.05.005_bib1","series-title":"Global tuberculosis control: WHO 2017 Report","author":"WHO","year":"2017"},{"key":"10.1016\/j.tube.2018.05.005_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2005.05.005","article-title":"Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis","volume":"26","author":"Bhusal","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.tube.2018.05.005_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tube.2017.02.004","article-title":"Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis","volume":"104","author":"Maltempe","year":"2017","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.tube.2018.05.005_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs","volume":"47","author":"Alcal\u00e1","year":"2003","journal-title":"Antimicrob agents chemother"},{"issue":"6","key":"10.1016\/j.tube.2018.05.005_bib5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tube.2013.09.001","article-title":"Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method","volume":"93","author":"Caleffi-Ferracioli","year":"2013","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.tube.2018.05.005_bib6","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob agents chemother"},{"issue":"9","key":"10.1016\/j.tube.2018.05.005_bib7","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1128\/AAC.44.9.2567-2568.2000","article-title":"In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs","volume":"44","author":"Ruiz-Serrano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.05.005_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method of testing synergy with any number of agentes","volume":"137","author":"Beranbaum","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2018.05.005_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0924-8579(02)00387-4","article-title":"Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis","volume":"21","author":"Rodriguez D\u00edaz","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2018.05.005_bib10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.40.7.1610","article-title":"In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis","volume":"40","author":"Rastogi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.05.005_bib11","first-page":"1","article-title":"In vitro synergism testing of three antimicrobial agents against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis by checkerboard method","volume":"3","author":"Yan","year":"2014","journal-title":"J Mol Pharm Org Process Res"},{"issue":"6","key":"10.1016\/j.tube.2018.05.005_bib12","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.02020-12","article-title":"Susceptibility testing of extensively drug-resistant and Pre extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate","volume":"57","author":"Ahmed","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.05.005_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis","volume":"169","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2018.05.005_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0732-8893(91)90002-W","article-title":"Oxazolidinone a new class of synthetic anti-tuberculosis agente: in vitro e in vivo activities of DuP-721 against Mycobacterium tuberculosis","volume":"14","author":"Ashtekar","year":"1991","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2018.05.005_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"69","author":"McGrath","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217304572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217304572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T11:43:03Z","timestamp":1569152583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979217304572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":15,"alternative-id":["S1472979217304572"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2018.05.005","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}